Phase 2 Breast Cancer Trial, Recruiting (NCT07396324)

Phase 2 Breast Cancer Trial, Recruiting NCT07396324 Sponsor: RenJi Hospital Condition: Breast Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07396324 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Breast Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are 18 years of age or older
People who have been diagnosed with breast cancer that has been confirmed by a lab test (biopsy), where the cancer is hormone receptor positive and HER2 negative
People who have at least one area of cancer that can be measured or tracked during the trial
People who are reasonably active and able to carry out daily activities (a performance level doctors rate as 0 or 1 on a standard scale)
People whose heart, liver, kidneys, and other organs are functioning well enough to meet the trial's health requirements

Who may not be able to join:

People whose breast cancer has spread to other parts of the body (known as Stage IV or metastatic disease)
Women who are pregnant, breastfeeding, or who test positive on a pregnancy test at the start of the trial
Women of childbearing potential who are not willing to use effective contraception throughout the entire trial period

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Wenjin Yin, Renji Hospital, School of Medicine, Shanghai Jiaotong University

Phone: 86(21)68385569

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07396324

Sponsor: RenJi Hospital

Phase: Phase 2

Status: Recruiting

Condition: Breast Cancer

Trial contact: 86(21)68385569

More information: https://clinicaltrials.gov/study/NCT07396324

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are 18 years of age or older
People who have been diagnosed with breast cancer that has been confirmed by a lab test (biopsy), where the cancer is hormone receptor positive and HER2 negative
People who have at least one area of cancer that can be measured or tracked during the trial
People who are reasonably active and able to carry out daily activities (a performance level doctors rate as 0 or 1 on a standard scale)
People whose heart, liver, kidneys, and other organs are functioning well enough to meet the trial's health requirements

Who may not be able to join:

People whose breast cancer has spread to other parts of the body (known as Stage IV or metastatic disease)
Women who are pregnant, breastfeeding, or who test positive on a pregnancy test at the start of the trial
Women of childbearing potential who are not willing to use effective contraception throughout the entire trial period

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 2

Sponsor

RenJi Hospital

Registry

ClinicalTrials.gov

Start date

1 May 2026

Est. completion

1 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Proportion of patients with pCR

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov